Interleukin-4 and Interleukin-10 Gene Polymorphisms in Patients with Inflammatory Bowel Disease

Immunological Investigations

Volumn 46, Issue 7, 2017, Pages 714-729

  Ebrahimi Daryani, Nasser ^a   Saghazadeh, Amene ^a,b   Moossavi, Shirin ^c   Sadr, Maryam ^a   Shahkarami, Sepideh ^a,b   Soltani, Samaneh ^a   Farhadi, Elham ^d   Rezaei, Nima ^a,b,e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSAL SCIENTIFIC EDUCATION AND RESEARCH NETWORK USERN   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Crohn s disease; genetics; IL 10; IL 4; inflammatory bowel disease; polymorphisms; Th2 cytokines; ulcerative colitis

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ODDS RATIO; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; ULCERATIVE COLITIS; GENETICS; INFLAMMATORY BOWEL DISEASE; IRAN; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTERLEUKIN-4; IRAN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 85029163608     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820139.2017.1360343     Document Type: Article

References (78)

1. Adler, K. B., B. M., Fischer, D. T., Wright, et al. (1994). “Interactions between respiratory epithelial cells and cytokines:relationships to lung inflammation.” Annals of the New York Academy of Sciences 725:128–145.
2. Ahirwar, D. K., P., Kesarwani, R., Singh, et al. (2012). “Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India.” Journal of gastrointestinal cancer 43(2):196–204.
3. Aithal, G. P., C. P., Day, J., Leathart, et al. (2001). “Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population.” Genes and immunity 2(1):44.
4. Almeida, N. P., G. O., Santana, T. C., Almeida, et al. (2013). “Polymorphisms of the cytokine genes TGFB1 and IL10 in a mixed-race population with Crohn's disease.” BMC Res Notes 6:387.
5. Amirzargar, A. A., M., Naroueynejad, F., Khosravi, et al. (2008). “Cytokine single nucleotide polymorphisms in Iranian populations.” Eur Cytokine Netw 19(2):104–112.
6. Amre, D. K., D. R., Mack, K., Morgan, et al. (2009). “Interleukin 10 (IL‐10) gene variants and susceptibility for paediatric onset Crohn’s disease.” Alimentary pharmacology & therapeutics 29(9):1025–1031.
7. Andersen, V., A., Ernst, J., Christensen, et al. (2010). “The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.” BMC medical genetics 11(1):82.
8. Balding, J., W. J., Livingstone, J., Conroy, et al. (2004). “Inflammatory bowel disease:the role of inflammatory cytokine gene polymorphisms.” Mediators of inflammation 13(3):181–187.
9. Barkhordari, E., N., Rezaei, M., Mahmoudi, et al. (2010). “T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome.” Inflammation 33(5):281–286.
10. Barrett, J. C., B., Fry, J., Maller, et al. (2004). “Haploview:analysis and visualization of LD and haplotype maps.” Bioinformatics 21(2):263–265.
11. Best, W. R., J. M., Becktel, J. W., Singleton, et al. (1976). ”Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study”. Gastroenterology 70(3):439–444.
12. Bidwell, J., L., Keen, G., Gallagher, et al. (1999). “Cytokine gene polymorphism in human disease:on-line databases.” Genes and immunity 1(1):3–19.
13. Brenner, A. V., M. A., Butler, S. S., Wang, et al. (2007). “Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma.” Carcinogenesis 28(12):2543–2547.
14. Cantor, M. J., P., Nickerson and C. N., Bernstein (2005). “The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.” The American journal of gastroenterology 100(5):1134–1142.
15. Castro-Santos, P., A., Suarez, L., López-Rivas, et al. (2006). ”TNFα and IL-10 gene polymorphisms in inflammatory bowel disease. Association of− 1082 AA low producer IL-10 genotype with steroid dependency”. The American journal of gastroenterology 101(5):1039–1047.
16. Castro-Santos, P., A., Suarez, L., Mozo, et al. (2007). “Association of IL-10 and TNFα genotypes with ANCA appearance in ulcerative colitis.” Clinical Immunology 122(1):108–114.
17. Çelik, Y., Ü., Dagli, M., Yalin Kiliç, et al. (2006). “Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.” Scandinavian journal of gastroenterology 41(5):559–565.
18. Chen, D., T. L., Zhang and X., Wang (2016). “Association between Polymorphisms in Interleukins 4 and 13 Genes and Chronic Periodontitis in a Han Chinese Population.” Biomed Res Int 2016:8389020.
19. Chen, J., Z., Liang, F., Lu, et al. (2011). “Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine.” Vaccine 29(4):706–711.
20. Chen, P., C., Chen, K., Chen, et al. (2015). “Polymorphisms in IL-4/IL-13 pathway genes and glioma risk:an updated meta-analysis.” Tumour Biol 36(1):121–127.
21. Connelly, T. M., W. A., Koltun, W., Sangster, et al. (2014). “An interleukin-4 polymorphism is associated with susceptibility to Clostridium difficile infection in patients with inflammatory bowel disease:Results of a retrospective cohort study.” Surgery 156(4):769–775.
22. de Jong, D. J., B., Franke, A. H., Naber, et al. (2003). “No evidence for involvement of IL-4R and CD11B from the IBD1 region and STAT6 in the IBD2 region in Crohn's disease.” Eur J Hum Genet 11(11):884–887.
23. Duerr, R. H., K. D., Taylor, S. R., Brant, et al. (2006). “A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.” science 314(5804):1461–1463.
24. Durães, C., J. C., Machado, F., Portela, et al. (2012). Phenotype -genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II). Inflamm Bowel Dis. doi:10.1002/ibd.23007
25. Fedorak, R. N., A., Gangl, C. O., Elson, et al. (2000). “Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease.” Gastroenterology 119(6):1473–1482.
26. Ferguson, L. R., D. Y., Han, C., Huebner, et al. (2008). “Single Nucleotide Polymorphisms in IL4, OCTN1 and OCTN2 Genes in As-sociation with Inflammatory Bowel Disease Phenotypes in a Caucasian Population in Canterbury, New Zealand.” Open Gastroenterology Journal 2:50–56.
27. Fernandez, L., A., Martinez, J. L., Mendoza, et al. (2005). “Interleukin-10 polymorphisms in Spanish patients with IBD.” Inflamm Bowel Dis 11(8):739–743.
28. Fowler, E. V., R., Eri, G., Hume, et al. (2005). “TNFα and IL10 SNPs act together to predict disease behaviour in Crohn’s disease.” Journal of medical genetics 42(6):523–528.
29. Franke, A., D. P. B., McGovern, J. C., Barrett, et al. (2010). “Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.” Nature genetics 42(12):1118–1125.
30. Fuss, I. J., M., Neurath, M., Boirivant, et al. (1996). “Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5”. The Journal of Immunology 157(3):1261.
31. Garza-Gonzalez, E., G. I., Perez-Perez, S. I., Mendoza-Ibarra, et al. (2010). “Genetic risk factors for inflammatory bowel disease in a North-eastern Mexican population.” Int J Immunogenet 37(5):355–359.
32. Gomes, P., C., du Boulay, C., L., Smith, et al. (1986). “Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease.” Gut 27(1):92–95.
33. Haddad, J. J., N. E., Saadé and B., Safieh-Garabedian (2002). “Cytokines and neuro–immune–endocrine interactions:a role for the hypothalamic–pituitary–adrenal revolving axis.” Journal of neuroimmunology 133(1):1–19.
34. Harrington, L. E., R. D., Hatton, P. R., Mangan, et al. (2005). “Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.” Nat Immunol 6(11):1123–1132.
35. Hedayat, M., M. J., Mahmoudi, N. R., Rose, et al. (2010). “Proinflammatory cytokines in heart failure:double-edged swords.” Heart failure reviews 15(6):543–562.
36. Hong, J., E., Leung, A. G., Fraser, et al. (2008). “IL4, IL10, IL16, and TNF polymorphisms in New Zealand Caucasian Crohn's disease patients.” Int J Colorectal Dis 23(3):335–337.
37. Hugot, J.-P., P., Laurent-Puig, C., Gower-Rousseau, et al. (1996). “Mapping of a susceptibility locus for Crohn's disease on chromosome 16.” Nature 379(6568):821.
38. Jin, T., X., Li, J., Zhang, et al. (2013). “Genetic association between selected cytokine genes and glioblastoma in the Han Chinese population.” BMC Cancer 13:236.
39. Jostins, L., S., Ripke, R. K., Weersma, et al. (2012). “Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.” Nature 491(7422):119–124.
40. Khurana Hershey, G. K., M. F., Friedrich, L. A., Esswein, et al. (1997). “The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor.” N Engl J Med 337(24):1720–1725.
41. Kim, T. H., B. G., Kim, H. D., Shin, et al. (2003). “Tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease.” The Korean journal of gastroenterology= Taehan Sohwagi Hakhoe chi 42(5):377–386.
42. Klausz, G., T., Molnár, F., Nagy, et al. (2005). “Polymorphism of the heat-shock protein gene Hsp70-2, but not polymorphisms of the IL-10 and CD14 genes, is associated with the outcome of Crohn's disease.” Scandinavian journal of gastroenterology 40(10):1197–1204.
43. Klein, W., A., Tromm, T., Griga, et al. (2001). “Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases.” Genes Immun 2(5):287–289.
44. Klein, W., A., Tromm, T., Griga, et al. (2000). “The IL‐10 gene is not involved in the predisposition to inflammatory bowel disease.” Electrophoresis 21(17):3578–3582.
45. Koss, K., J., Satsangi, G. C., Fanning, et al. (2000). “Cytokine (TNF [alpha], LT [alpha] and IL-10) polymorphisms in inflammatory bowel diseases and normal controls:differential effects on production and allele frequencies.” Genes and immunity 1(3):185.
46. Kucharzik, T., R., Stoll, N., Lügering, et al. (1995). “Circulating antiinflammatory cytokine IL‐10 in patients with inflammatory bowel disease (IBD).” Clinical & Experimental Immunology 100(3):452–456.
47. Li, W., X., Qian, H., Teng, et al. (2014). “Association of interleukin-4 genetic polymorphisms with sporadic Alzheimer's disease in Chinese Han population.” Neurosci Lett 563:17–21.
48. Lippitz, BE., Cytokine patterns in patients with cancer:a systematic review. The lancet oncology. 2013 May 31;14(6):e218–28.
49. Lv, H., Y., Jiang, J., Li, et al. (2014). “Association between polymorphisms in the promoter region of interleukin-10 and susceptibility to inflammatory bowel disease.” Molecular biology reports 41(3):1299–1310.
50. Maynard, C. L., C. O., Elson, R. D., Hatton, et al. (2012). “Reciprocal interactions of the intestinal microbiota and immune system.” Nature 489(7415):231–241.
51. Mendoza, J. L., E., Urcelay, R., Lana, et al. (2006). “Polymorphisms in the interleukin-10 gene and relation to phenotype in patients with ulcerative colitis.” Rev Esp Enferm Dig 98(2):93–100.
52. Mijac, D., I. V., Petrovic, S., Djuranovic, et al. (2016). “The Polymorphism rs3024505 (C/T) Downstream of the IL10 Gene Is Associated with Crohn's Disease in Serbian Patients with Inflammatory Bowel Disease.” Tohoku J Exp Med 240(1):15–24.
53. Nelms, K., A. D., Keegan, J., Zamorano, et al. (1999). “The IL-4 receptor:signaling mechanisms and biologic functions.” Annual review of immunology 17(1):701–738.
54. Niessner M, Volk, BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT–PCR). Clinical & Experimental Immunology. 1995 Sep 1;101(3):428–35.
55. Noack, M., and P., Miossec (2014). “Th17 and regulatory T cell balance in autoimmune and inflammatory diseases.” Autoimmunity reviews 13(6):668–677.
56. Olavesen, M. G., J., Hampe, M. M., Mirza, et al. (2000). “Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease.” Immunogenetics 51(1):1–7.
57. Onnie, C., S. A., Fisher, K., King, et al. (2006). “Sequence variation, linkage disequilibrium and association with Crohn's disease on chromosome 5q31.” Genes and immunity 7(5):359–365.
58. Rad, R., A., Dossumbekova, B., Neu, et al. (2004). “Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection.” Gut 53(8):1082–1089.
59. Rennick, D. M., and M. M., Fort (2000). “XII. IL-10-deficient (IL-10−/−) mice and intestinal inflammation.” American Journal of Physiology-Gastrointestinal and Liver Physiology 278(6):G829–G833.
60. Rioux, J. D., M. J., Daly, M. S., Silverberg, et al. (2001). “Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease.” Nat Genet 29(2):223–228.
61. Rioux, J. D., M. S., Silverberg, M. J., Daly, et al. (2000). “Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci.” The American Journal of Human Genetics 66(6):1863–1870.
62. Rosenwasser, L. J., and L., Borish (1997). “Genetics of atopy and asthma:the rationale behind promoter-based candidate gene studies (IL-4 and IL-10).” American journal of respiratory and critical care medicine 156(4):S152–S155.
63. Rosenwasser, L. J., D. J., Klemm, J. K., Dresback, et al. (1995). “Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy.” Clinical & Experimental Allergy 25(s2):74–78.
64. Sakaguchi, S., (2004). “Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses.” Annu. Rev. Immunol. 22:531–562.
65. Sanchez, R., E., Levy, F., Costea, et al. (2009). “IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location.” World J Gastroenterol 15(30):3776–3782.
66. Schreiber, S., R. N., Fedorak, O. H., Nielsen, et al. (2000). “Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease.” Gastroenterology 119(6):1461–1472.
67. Schreiber, S., T., Heinig, H.-G., Thiele, et al. (1995). “Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.” Gastroenterology 108(5):1434–1444.
68. Sellon, R. K., S., Tonkonogy, M., Schultz, et al. (1998). “Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.” Infection and immunity 66(11):5224–5231.
69. Shiotani, A., H., Kusunoki, Y., Kimura, et al. (2013). “S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome.” Dig Dis Sci 58(8):2314–2323.
70. Sternberg, E. M., (1997). “Neural-immune interactions in health and disease.” Journal of Clinical Investigation 100(11):2641.
71. Tagore, A., W. M., Gonsalkorale, V., Pravica, et al. (1999). “Interleukin‐10 (IL‐10) genotypes in inflammatory bowel disease.” HLA 54(4):386–390.
72. Tavares, M., C., de Lima, W., Fernandes, et al. (2016). “Tumour necrosis factor-alpha (-308G/A) promoter polymorphism is associated with ulcerative colitis in Brazilian patients.” Int J Immunogenet 43(6):376–382.
73. Tedde, A., A., Laura Putignano, S., Bagnoli, et al. (2008). “Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner.” Scand J Gastroenterol 43(6):712–718.
74. Wang, A. H., W.-J., Lam, D.-Y., Han, et al. (2011). “The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population.” Human immunology 72(5):431–435.
75. Wang, J., and S., Shete (2010). “Using Both Cases and Controls for Testing Hardy-Weinberg Proportions in a Genetic Association Study.” Human Heredity 69(3):212–218.
76. Wu, H., J., Guo, Y., He, et al. (2016). “Relationship between IL-10 gene -819C/T polymorphism and the risk of inflammatory bowel disease:a meta-analysis.” Afr Health Sci 16(3):866–872.
77. Zhao, B., and J. P., Schwartz (1998). “Involvement of cytokines in normal CNS development and neurological diseases:recent progress and perspectives.” Journal of neuroscience research 52(1):7–16.
78. Zhu, H., X., Lei, Q., Liu, et al. (2013). “Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility:a meta-analysis based on 17,585 subjects.” Cytokine 61(1):146–153.